Can I take Zofran (ondansetron) and Atarax (hydroxyzine) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Take Zofran and Atarax Together?

Yes, you can take Zofran (ondansetron) and Atarax (hydroxyzine) together, but this combination requires careful cardiac monitoring due to additive QT-interval prolongation risk. 1

Primary Safety Concern: QT Prolongation

Both medications independently prolong the QT interval, and their combination increases the risk of torsades de pointes, a potentially fatal cardiac arrhythmia. 2, 1

Specific Risk Factors to Assess Before Combining

Before using these medications together, evaluate for:

  • Pre-existing heart disease, recent myocardial infarction, uncompensated heart failure, or bradyarrhythmias 1
  • Congenital long QT syndrome or family history of long QT syndrome 1
  • Electrolyte abnormalities, particularly hypokalemia or hypomagnesemia 2, 1
  • Concurrent use of other QT-prolonging medications (see list below) 2, 1

Mandatory Precautions When Using Together

Obtain a baseline electrocardiogram before initiating combination therapy to assess the QT interval, especially if any cardiac risk factors are present. 2

Check and correct serum potassium and magnesium levels prior to starting treatment, as electrolyte deficiencies significantly heighten cardiac toxicity risk. 2

Limit ondansetron to a maximum of 8 mg per dose to minimize QT prolongation risk. 2, 3

Medications That Further Increase Risk

The FDA label for hydroxyzine specifically warns about combining it with ondansetron and other QT-prolonging drugs. 1 Additional medications that compound this risk include:

  • Antiarrhythmics: quinidine, procainamide, amiodarone, sotalol 1
  • Antipsychotics: ziprasidone, iloperidone, clozapine, quetiapine, chlorpromazine 2, 1
  • Antidepressants: citalopram, fluoxetine 1
  • Antibiotics: azithromycin, erythromycin, clarithromycin, moxifloxacin 2, 1
  • Other antihistamines: diphenhydramine, loratadine 2

Central Nervous System Depression

Hydroxyzine potentiates the effects of other CNS depressants, requiring dose reduction when combined with narcotics, non-narcotic analgesics, or barbiturates. 1

  • Warn patients about increased drowsiness and caution against driving or operating machinery 1
  • Advise against alcohol use, as hydroxyzine increases alcohol's effects 1
  • Start elderly patients on low doses of hydroxyzine due to increased risk of confusion and over-sedation 1

Clinical Context for Combined Use

This combination is most commonly used when ondansetron alone fails to control nausea. 2 The NCCN guidelines note that hydroxyzine may be useful for opioid-induced pruritus when administered with ondansetron for nausea control. 2

Ondansetron combined with dexamethasone remains the gold-standard regimen for chemotherapy-induced nausea and vomiting, and should be considered before adding hydroxyzine. 2, 3

Safer Alternative Combinations

If additional antiemetic effect is needed beyond ondansetron alone:

  • Add dexamethasone (4-12 mg) for synergistic antiemetic benefit without QT-prolongation concerns 2, 3
  • Consider metoclopramide (10-20 mg) or prochlorperazine as alternatives to hydroxyzine 2
  • Lorazepam (0.5-2 mg every 4-6 hours) can be added for anticipatory nausea without cardiac risk 2

Special Populations

In elderly patients, start hydroxyzine at the low end of the dosing range due to greater frequency of decreased hepatic, renal, or cardiac function. 1

In pregnant patients with hyperemesis gravidarum, ondansetron should only be used as second-line therapy after 10 weeks of gestation due to potential cardiac defect risk in the first trimester. 2

Common Pitfall to Avoid

Do not assume therapeutic doses are automatically safe together—the QT prolongation risk exists even at standard dosing of both medications when combined. 1 The interaction is dose-dependent and cumulative, making cardiac monitoring essential rather than optional.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Concurrent Use of Itopride and Ondansetron: Safety and Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are alternative medications to ondansetron (Zofran) for preventing nausea and vomiting?
What is the appropriate dose of ondansetron (antiemetic medication) for a pediatric patient weighing 19.5kg?
What is the recommended dose and administration of Zofran (ondansetron) via intramuscular (IM) injection for an 11-month-old patient?
Should a 31-year-old female with a history of Nexplanon (etonogestrel implant) complications, presenting with left upper arm pain radiating to the wrist and thumb, and right arm burning pain at the antecubital (A/C) site, be evaluated in person or can she receive a refill for Ondansetron HCl (ondansetron hydrochloride) over the phone?
What formulations of ondansetron are marketed in Argentina and what are the recommended dosing regimens for children (≥6 months), adolescents, and adults?
How should I interpret a patient’s complete blood count showing normocytic, normochromic anemia with high red‑cell distribution width, marked neutrophilia and lymphopenia, and a comprehensive metabolic panel revealing low chloride, metabolic alkalosis, elevated blood urea nitrogen with normal creatinine, low total protein and albumin, and an estimated glomerular filtration rate of 79 mL/min/1.73 m², and what immediate management steps are recommended?
Can ondansetron 4 mg be administered twice daily instead of a single 8 mg or 16 mg daily dose?
How is autoimmune hepatitis diagnosed and treated in a young adult woman presenting with unexplained elevated transaminases, increased IgG (immunoglobulin G), and positive ANA (antinuclear antibody) or SMA (smooth muscle antibody)?
What is your definitive treatment recommendation for this patient?
What is the minimum age required to take Ubrelvy (ubrogepant)?
What is the appropriate evaluation and management for a patient presenting with hives (urticaria) and swollen joints?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.